A02 RFI Chemical Sterilant-Final.docx
DOCX document 42 KB Posted
- Attached to
- RFI-Chemical Sterilant
- Solicitation number
- HT9425-24-01-RFIJMC
- Issued by
-
Department of the Army Medical Command
About this file
This document is a Request for Information (RFI) issued by the US Army Medical Materiel Development Activity (USAMMDA) Warfighter Expeditionary Medicine Treatment Project Management Office (WEMT PMO) to obtain information from industry on a fast-acting chemical sterilant.
The RFI states that WEMT PMO has a requirement for a chemical sterilant in powder or liquid form that can be mixed with potable water to sterilize surgical instruments and other medical equipment within 10 minutes. The sterilant must be FDA-cleared and EPA-approved, and be able to be reused and disposed of as a non-hazardous liquid. WEMT PMO is seeking information from industry on their ability to provide such a sterilant in a concentrated form to reduce logistical burdens. Interested parties are requested to submit responses electronically by June 6, 2024. No contract will be awarded based on this RFI, which is for information and planning purposes only.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A02 Attachment 1-Final.docx | DOCX document | |
| A02 Attachment 2 for RFI Company Information-Final.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
REQUEST FOR INFORMATION (RFI)
Fast Acting Chemical Sterilant
THIS IS NOT A REQUEST FOR PROPOSALS (RFP) OR A REQUEST FOR QUOTATIONS
(RFQ); IT IS STRICTLY A REQUEST FOR INFORMATION (RFI). NEITHER UNSOLICITED PROPOSALS NOR ANY OTHER KINDS OF OFFERS WILL BE CONSIDERED IN RESPONSE TO THIS RFI. NO CONTRACT/ORDER WILL BE AWARDED PURSUANT TO THIS ANNOUNCEMENT.
Disclaimer: The purpose of this RFI notice is to gain market knowledge. This notice does not obligate the Government to award a contract/order or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's solution and qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a synopsis and/or solicitation may or may NOT be published at a future date and time.
1. RFI Number: HT9425-24-R-01RFIJMC
2. RFI Issuing Office: United States Army Medical Research Acquisition Activity (USAMRAA)
3. RFI Issue Date: 22 April 2024
4. RFI Title: Fast Acting Chemical Sterilant
5. Agency: US Army Medical Materiel Development Activity (USAMMDA)
6. Office: Warfighter Expeditionary Medicine Treatment Project Management Office (WEMT PMO)
7. Agency Location: Frederick, MD located on Fort Detrick
8. Contract Type: unknown In accordance with Federal Acquisition Regulation (FAR) 15.201 "Exchanges with Industry Before Receipt of Proposals" and FAR 52.215-3, "Request for Information or Solicitation for Planning Purposes" this Request for Information (RFI) is for information and planning purposes only at this time and shall not be construed as a solicitation or as an obligation on the part of the USAMRAA, USAMMDA or WEMT PMO.
This RFI is for information and planning purposes only and is neither to be construed as a commitment by the Government nor will the Government pay for information solicited. Respondents are solely responsible for all expenses associated with responding to this RFI. No evaluation letters and/or results will be issued to the respondents. Currently, no solicitation exists; therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPT OR RETURNED.
9. Background: The WEMT PMO of USAMMDA is conducting market research to determine whether a commercial solution can be provided to meet requirements for a Chemical Sterilant that sterilizes surgical or medical tools in ten (10) minutes. This market research may also assist with the further development and/or refinement of the requirements.
10. Objective and Purpose/Scope: The WEMT PMO of USAMMDA has a requirement to provide a fast-acting chemical sterilant to medical roles and teams that lack or have limited access to electrical power and transportation. The Chemical Sterilant capability will be a powder or liquid, which when added to and mixed with potable water, will result in a liquid solution capable of sterilizing surgical instruments or other medical materiel through immersion, ideally within ten (10) minutes. After mixing, it will be reusable and disposable as a non-hazardous liquid. It will have the required approvals from the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA).
Many of the commercially available Chemical Sterilants are available, ready to use, in large volumes or require multiple hours of immersion to achieve sterilization. Sterilizers that require power with long cycle times and transporting large volumes of liquids can be logistical burdens. WEMT is requesting information from commercial markets about the ability to provide an FDA-Cleared Chemical Sterilant with a sterilization indication in a concentrated form to reduce logistical burdens. Additionally, WEMT would like to understand the potential or challenge of an FDA-Cleared Chemical Sterilant to sterilize within ten (10) minutes.
11. North American Industry Classification System (NAICS) Code: Unknown
12. RFI Attachments: The following documents are attached to the RFI:
| i. A02-RFI-Attachment-1-Questions to Vendors |
| ii. A02-RFI-Attachment-2-Company-Information |
12.1. Questions to Vendors (RFI Attachment 1). As part of your RFI response, please address the questions in Attachment 1. The attached is for information and planning purposes only.
12.2. RFI Capabilities Statement (RFI Attachment 2). As part of your RFI response, please complete the Capabilities Statement. The attached is for information and planning purposes only.
13. Response Due Date: Interested parties shall submit the RFI response electronically by 1:00 pm Eastern, 6 June 2024 via e-mail to:
| Jeanette Collins |
| Jeanette.m.collins4.civ@health.mil |
14. Instructions to Respondents:
14.1 The Government appreciates responses from ALL capable and qualified sources.
14.2 Interested firms should submit a response that demonstrates the Respondent's ability to perform the scope of work identified in this RFI.
14.3 Format specifications include Arial 12-point font, single spaced, single sided, 8.5 by 11- inch paper with 1-inch margins. All submissions shall be made electronically (as described above) and be in one of the following formats: Microsoft Word or searchable Adobe PDF.
Responses should adhere to the following formatting and outline instructions:
Cover Page (1page)
· Title
· Organization
· Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)
· Topic area(s) addressed.
14.4 Completed Attachment 1 and Attachment 2. Please note that the response shall provide sufficient technical data to determine how you fully meet the requirements as specified in Attachment 2.
15.0 Confidentiality: All 'Proprietary', 'Classified', 'Confidential', or 'Sensitive' information shall be marked as such and will be treated accordingly. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
(End of RFI)
File details come from the government source that posted it. Updated .